During the past decade, Department of Internal Diseases, Diabetology and Nephrology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Internal Diseases, Diabetology and Nephrology" #1 collaborator was "Sanprobi Sp. z o.o., Sp. k., Szczecin, Poland" with 1 trials as a collaborator, "Silesian University of Technology" with 1 trials as a collaborator and "University of Liverpool" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Department of Internal Diseases, Diabetology and Nephrology" are "Diabetes Mellitus" (1 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Metformin Adverse Reaction" (1 trials). Many other conditions were trialed in "Department of Internal Diseases, Diabetology and Nephrology" in a lesser frequency.

Most popular intervention types in "Department of Internal Diseases, Diabetology and Nephrology" are "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo Comparator" (1 trials) and "Sanprobi Barrier-multispecies probiotic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Internal Diseases, Diabetology and Nephrology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Department of Internal Diseases, Diabetology and Nephrology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Department of Internal Diseases, Diabetology and Nephrology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Internal Diseases, Diabetology and Nephrology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".